ArticleCell death discovery2025

VANGL2 downregulates HINT1 to inhibit the ATM-p53 pathway and promote cisplatin resistance in small cell lung cancer.

Jiayi Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.